These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15964484)

  • 1. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the long-term protection after hepatitis A and B vaccination.
    Van Damme P; Van Herck K
    Travel Med Infect Dis; 2007 Mar; 5(2):79-84. PubMed ID: 17298912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antibody response and immunologic memory in children immunized with hepatitis B vaccine at birth.
    Saffar MJ; Rezai MS
    Indian Pediatr; 2004 Dec; 41(12):1232-7. PubMed ID: 15623904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.
    FitzSimons D; Hendrickx G; Vorsters A; Van Damme P
    Vaccine; 2013 Jan; 31(4):584-90. PubMed ID: 23142301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term protection of hepatitis B vaccine 18 years after vaccination.
    Alfaleh F; Alshehri S; Alansari S; Aljeffri M; Almazrou Y; Shaffi A; Abdo AA
    J Infect; 2008 Nov; 57(5):404-9. PubMed ID: 18829116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The worldwide impact of vaccination on the control and protection of viral hepatitis B.
    Romano' L; Paladini S; Van Damme P; Zanetti AR
    Dig Liver Dis; 2011 Jan; 43 Suppl 1():S2-7. PubMed ID: 21195368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and the need for a booster dose.
    Leuridan E; Van Damme P
    Clin Infect Dis; 2011 Jul; 53(1):68-75. PubMed ID: 21653306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current status of hepatitis B immunization and strengthened immune memory among first-year middle school students in Tianjin].
    Shan AL; Li C; Wu WS; He HY; Liu Y; Liu P; Xie XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Jun; 44(6):531-4. PubMed ID: 21055129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
    Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination.
    Sjogren MH
    Am J Med; 2005 Oct; 118 Suppl 10A():34S-39S. PubMed ID: 16271539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Kao JT; Wang JH; Hung CH; Yen YH; Hung SF; Hu TH; Lee CM; Lu SN
    Vaccine; 2009 Mar; 27(12):1858-62. PubMed ID: 19186203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B.
    Can Commun Dis Rep; 1992 Aug; 18(16):121-2. PubMed ID: 1290997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Why are boosters no longer necessary for protection against hepatitis B?].
    Siegrist CA
    Rev Prat; 2004 Mar; 54(5):509-11. PubMed ID: 15176509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.